Relationship of Handgrip Strength and Body Mass Index With Cognitive Function in Patients With Schizophrenia.

Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101545006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-0640 (Print) Linking ISSN: 16640640 NLM ISO Abbreviation: Front Psychiatry Subsets: PubMed not MEDLINE

Original Publication: Switzerland : Frontiers Research Foundation, 2010-

Background: The relationship between muscle strength and cognition in schizophrenia has not been well studied. We investigated the potential relationship of handgrip strength (HGS) score and body mass index (BMI) with cognitive function in patients with schizophrenia. Methods: Participants included 153 patients with schizophrenia (age: 36.9 ± 9.4 years; 82 males) and 328 healthy controls (age: 36.4 ± 10.7 years; 150 males), matched for age, sex, and ethnicity (Japanese). HGS was measured using a digital handgrip dynamometer. Cognitive function was evaluated using the Brief Assessment of Cognition in Schizophrenia (BACS) test. A two-way multivariate analysis of covariance was used to compare HGS scores between the patient and control groups. Multiple regression analyses of BACS scores were performed in the patient and control groups using HGS and BMI scores as independent variables. Results: In the intergroup comparison, significantly lower HGS scores were observed in patients with schizophrenia than in healthy controls ( p < 0.05, corrected). In the patient group, there was a significantly positive correlation between HGS scores and BACS composite score (male, p = 0.0014; female, p = 0.0051). However, BMI scores were significantly negatively correlated with the BACS composite score (male, p = 0.0022; female, p = 0.018). Furthermore, the ratio of HGS/BMI was significantly positively correlated with the BACS composite score in the patient group ( p = 0.00000018). Conclusions: Cognitive function in patients with schizophrenia is correlated positively with HGS and negatively with BMI. HGS/BMI may thus be a good index for cognitive performance in schizophrenia.

Schizophr Bull. 2015 Jul;41(4):859-68. (PMID: 25805886)
Psychiatry Clin Neurosci. 1998 Oct;52(5):467-70. (PMID: 10215006)
Curr Behav Neurosci Rep. 2016 Jun;3(2):165-175. (PMID: 27766192)
Psychiatry Res. 2013 May 15;207(1-2):25-32. (PMID: 23051886)
Epidemiol Rev. 2013;35:33-50. (PMID: 23349427)
Psychiatry Clin Neurosci. 2015 Aug;69(8):440-7. (PMID: 25601291)
Schizophr Bull. 2016 Jul;42 Suppl 1:S44-52. (PMID: 27460618)
Schizophr Res. 2004 Jun 1;68(2-3):283-97. (PMID: 15099610)
Geriatr Gerontol Int. 2016 Jan;16(1):5-20. (PMID: 26016893)
Psychiatry Clin Neurosci. 2005 Oct;59(5):517-26. (PMID: 16194252)
J Int Med Res. 2017 Apr;45(2):540-548. (PMID: 28415923)
Int J Obes (Lond). 2015 Feb;39(2):199-207. (PMID: 24984753)
Brain Pathol. 2016 Sep;26(5):648-63. (PMID: 27328058)
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57. (PMID: 9881538)
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253. (PMID: 11234459)
Acta Psychiatr Scand. 2015 Aug;132(2):97-108. (PMID: 26016380)
CNS Neurol Disord Drug Targets. 2017;16(6):638-651. (PMID: 28017130)
Clin Nutr. 2005 Apr;24(2):250-8. (PMID: 15784486)
J Nerv Ment Dis. 2014 Dec;202(12):845-52. (PMID: 25380399)
Front Hum Neurosci. 2016 Jul 29;10:373. (PMID: 27524962)
Psychiatry Res. 2012 Dec 30;200(2-3):73-8. (PMID: 22497956)
CNS Neurol Disord Drug Targets. 2015;14(10):1244-54. (PMID: 26556069)
Clin Nutr. 2008 Jun;27(3):357-62. (PMID: 18455840)
Schizophr Res Cogn. 2014 Jun;1(2):112-121. (PMID: 25254158)
Psychol Med. 2016 Aug;46(11):2375-84. (PMID: 27283122)
Age Ageing. 2011 Jan;40(1):14-23. (PMID: 20843964)
Psychiatry Res. 2014 Dec 30;220(3):784-91. (PMID: 25219618)
Br J Pharmacol. 2017 Oct;174(19):3161-3172. (PMID: 28261797)
JAMA. 2013 Nov 27;310(20):2191-4. (PMID: 24141714)
Psychiatry Res. 2016 Oct 30;244:394-402. (PMID: 27525830)
Psychiatry Clin Neurosci. 2007 Dec;61(6):602-9. (PMID: 18081619)
Neuropsychology. 1998 Jul;12(3):426-45. (PMID: 9673998)
J Affect Disord. 2018 Jan 1;225:188-194. (PMID: 28837952)
Nutr Today. 2015 May;50(3):117-128. (PMID: 27340299)
Psychiatr Danub. 2015 Mar;27(1):2-13. (PMID: 25751427)
Eur Arch Psychiatry Clin Neurosci. 2013 Sep;263(6):451-67. (PMID: 23873090)
Schizophr Res. 2017 May 12;:null. (PMID: 28506706)
Biogerontology. 2017 Aug;18(4):477-483. (PMID: 28492999)
BMC Psychiatry. 2013 Apr 09;13:109. (PMID: 23570390)
Eur Psychiatry. 2012 Aug;27(6):416-21. (PMID: 21398095)
Schizophr Res. 2016 Apr;172(1-3):213-5. (PMID: 26852401)
Curr Opin Psychiatry. 2017 May;30(3):171-175. (PMID: 28230631)
Schizophr Bull. 1987;13(2):261-76. (PMID: 3616518)
J Bodyw Mov Ther. 2017 Apr;21(2):401-413. (PMID: 28532885)
Ageing Res Rev. 2017 May;35:112-123. (PMID: 28189666)

Keywords: body mass index; cognitive function; handgrip strength; physical activity; schizophrenia

Date Created: 20180511 Latest Revision: 20220321

20231215

PMC5930849

10.3389/fpsyt.2018.00156

29743873